CA1069823A - Solution d'oxazepine administree par vole orale ou parenterale - Google Patents

Solution d'oxazepine administree par vole orale ou parenterale

Info

Publication number
CA1069823A
CA1069823A CA256,154A CA256154A CA1069823A CA 1069823 A CA1069823 A CA 1069823A CA 256154 A CA256154 A CA 256154A CA 1069823 A CA1069823 A CA 1069823A
Authority
CA
Canada
Prior art keywords
oxazepine
chloro
solution
dibenz
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA256,154A
Other languages
English (en)
Inventor
James A. Lowery
Lawrence Ritter
James E. Krueger
Bruce E. Haeger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of CA1069823A publication Critical patent/CA1069823A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
CA256,154A 1975-08-06 1976-07-02 Solution d'oxazepine administree par vole orale ou parenterale Expired CA1069823A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60233175A 1975-08-06 1975-08-06

Publications (1)

Publication Number Publication Date
CA1069823A true CA1069823A (fr) 1980-01-15

Family

ID=24410918

Family Applications (1)

Application Number Title Priority Date Filing Date
CA256,154A Expired CA1069823A (fr) 1975-08-06 1976-07-02 Solution d'oxazepine administree par vole orale ou parenterale

Country Status (19)

Country Link
JP (1) JPS5221313A (fr)
AR (1) AR210501A1 (fr)
AT (1) AT345464B (fr)
AU (1) AU500641B2 (fr)
BE (1) BE844903A (fr)
CA (1) CA1069823A (fr)
DE (1) DE2633943A1 (fr)
DK (1) DK147727C (fr)
EG (1) EG12425A (fr)
ES (1) ES450520A1 (fr)
FI (1) FI762171A (fr)
FR (1) FR2320102A1 (fr)
GB (1) GB1546933A (fr)
IL (1) IL49996A (fr)
NL (1) NL7608575A (fr)
NO (1) NO146457C (fr)
PT (1) PT65400B (fr)
SE (1) SE431716B (fr)
ZA (1) ZA764052B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404735B2 (en) 2009-03-18 2013-03-26 Omnipharm Limited Parasiticidal formulation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739254B1 (fr) * 1995-09-29 1997-12-19 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
FR2739255B1 (fr) * 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404735B2 (en) 2009-03-18 2013-03-26 Omnipharm Limited Parasiticidal formulation
US8580837B2 (en) 2009-03-18 2013-11-12 Fidopharm, Inc. Parasiticidal formulation
US8829038B2 (en) 2009-03-18 2014-09-09 Velcera, Inc. Parasiticidal formulation

Also Published As

Publication number Publication date
IL49996A (en) 1981-01-30
AU1577576A (en) 1978-01-12
NO146457C (no) 1982-10-06
DK354076A (da) 1977-02-07
FR2320102A1 (fr) 1977-03-04
AR210501A1 (es) 1977-08-15
AU500641B2 (en) 1979-05-31
BE844903A (fr) 1977-02-07
FI762171A (fr) 1977-02-07
DK147727C (da) 1985-06-17
EG12425A (en) 1979-06-30
NO762713L (fr) 1977-02-08
GB1546933A (en) 1979-05-31
SE7608810L (sv) 1977-02-07
DK147727B (da) 1984-11-26
NO146457B (no) 1982-06-28
JPS5221313A (en) 1977-02-17
ES450520A1 (es) 1978-05-01
DE2633943A1 (de) 1977-02-17
SE431716B (sv) 1984-02-27
ZA764052B (en) 1977-06-29
PT65400A (en) 1976-08-01
AT345464B (de) 1978-09-25
ATA581376A (de) 1978-01-15
NL7608575A (nl) 1977-02-08
PT65400B (en) 1978-01-27
IL49996A0 (en) 1976-09-30

Similar Documents

Publication Publication Date Title
RU2260429C9 (ru) Составы моксифлоксацина, содержащие поваренную соль
HUT77358A (hu) Propofolt és etilén-diamin-tetraecetsav-származékot tartalmazó "olaj a vízben" emulziók
NZ245112A (en) Pharmaceutical composition comprising a camptothecin analog and a platinum coordination compound
KR19990063669A (ko) 신규 방법
EP0359184B1 (fr) Solutions d'etoposide
WO2018167627A1 (fr) Composition pharmaceutique de suspension orale d'agents d'alkylation anti-néoplasiques
CA1069823A (fr) Solution d'oxazepine administree par vole orale ou parenterale
KR100929320B1 (ko) 리바비린 시럽 제형
CA2404298A1 (fr) Solution parenterale contenant de l'amiodarone
JPH0717498B2 (ja) 鎮咳去痰ソフトカプセル剤
US5935967A (en) Pharmaceutical formulations of highly lipophilic camptothecin derivatives
JPS615011A (ja) 安定なビタミンｅの可溶化液
US4049809A (en) Solution of a oxazepine for oral or parenteral administration
CA2188297C (fr) Formulation stable sous forme lactone de camptothecine ou 7-ethyle camptothecine
JPH0473411B2 (fr)
US6048874A (en) Parenteral metolazone formulations
US6818662B2 (en) Pharmaceutical composition
JP2002080347A (ja) 鉄化合物配合内服液剤
JPH0698729A (ja) 朝鮮人参エキス含有飲料とその製造方法
JPS6344517A (ja) 非経口的投与用溶液
JP2822049B2 (ja) 水性製剤組成物
WO2002078605A3 (fr) Solution parenterale premelangee a base d'amiodarone et son procede de fabrication
JPH04235925A (ja) 安定な総合ビタミン注射液
JPH0283323A (ja) 安定な酪酸リボフラビン水溶液
JP2846657B2 (ja) ボツリヌス菌外毒素に対する抗毒素剤

Legal Events

Date Code Title Description
MKEX Expiry